Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study

di Neri, Luca, McEwan, Phil, Sennfält, Karin, Baboolal, Kesh
Pubblicazione 2012

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK

di Bennett, Hayley, McEwan, Phil, Bergenheim, Klas, Gordon, Jason
Pubblicato in Diabetes Ther (2014)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus

di Gordon, Jason, McEwan, Phil, Hurst, Michael, Puelles, Jorge
Pubblicato in Diabetes Ther (2016)

A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice

di Evans, Marc, McEwan, Phil, O’Shea, Richard, George, Lindsay
Pubblicazione 2012

Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study

di Pockett, Rhys D., Watkins, John, McEwan, Phil, Meier, Genevieve
Pubblicato in PLoS One (2015)

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes mo...

di Bennett, Hayley, McEwan, Phil, Hamilton, Karina, O’Reilly, Karl
Pubblicato in BMC Nephrol (2019)

Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Aloglipt...

di Strain, W. David, McEwan, Phil, Howitt, Heena, Meadowcroft, Simon
Pubblicato in Diabetes Ther (2019)

Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom

di Gordon, Jason, Evans, Marc, McEwan, Phil, Bain, Steve, Vora, Jiten
Pubblicazione 2013

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future I...

di Bennett, Hayley, McEwan, Phil, Sugrue, Daniel, Kalsekar, Anupama, Yuan, Yong
Pubblicato in PLoS One (2015)

The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus

di McEwan, Phil, Bennett, Hayley, Fellows, Jonathan, Priaulx, Jennifer, Bergenheim, Klas
Pubblicato in PLoS One (2016)

Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care‐based cohort study, with economic assessment of patient outcomes

di Gordon, Jason, McEwan, Phil, Evans, Marc, Puelles, Jorge, Sinclair, Alan
Pubblicato in Diabetes Obes Metab (2017)

Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study

di Gordon, Jason, McEwan, Phil, Idris, Iskandar, Evans, Marc, Puelles, Jorge
Pubblicato in BMJ Open Diabetes Res Care (2018)

Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009

di Meier, Geneviève C., Watkins, John, McEwan, Phil, Pockett, Rhys D.
Pubblicato in PLoS One (2020)

The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes—A Systematic Literature Review

di Palaka, Eirini, Grandy, Susan, van Haalen, Heleen, McEwan, Phil, Darlington, Oliver
Pubblicato in Int J Nephrol (2020)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus

di McEwan, Phil, Webster, Samantha, Ward, Thomas, Brenner, Michael, Kalsekar, Anupama, Yuan, Yong
Pubblicato in Cost Eff Resour Alloc (2017)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

di Pochopien, Michal, Beiderbeck, Annette, McEwan, Phil, Zur, Richard, Toumi, Mondher, Aballéa, Samuel
Pubblicato in BMC Health Serv Res (2019)

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes

di Evans, Marc, Hicks, Debbie, Patel, Dipesh, Patel, Vinod, McEwan, Phil, Dashora, Umesh
Pubblicato in Diabetes Ther (2019)

Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes

di Evans, Marc, Hicks, Debbie, Patel, Dipesh, Patel, Vinod, McEwan, Phil, Dashora, Umesh
Pubblicato in Diabetes Ther (2019)

Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease: a systematic review and clinicia...

di Gordon, Jason P., McEwan, Phil C., Maguire, Andy, Sugrue, Daniel M., Puelles, Jorge
Pubblicato in Eur J Gastroenterol Hepatol (2015)

External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions

di Lopes, Sandra, Johansen, Pierre, Lamotte, Mark, McEwan, Phil, Olivieri, Anamaria-Vera, Foos, Volker
Pubblicato in Pharmacoeconomics (2020)